Literature DB >> 6403142

Controlled trial of cimetidine for symptomatic treatment of duodenal ulcers.

P Lance, B G Gazzard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6403142      PMCID： PMC1547333          DOI： 10.1136/bmj.286.6369.937-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Model of medical treatment for duodenal ulcer.

Authors:  R E Pounder
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

2.  Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study.

Authors:  W L Burland; B W Hawkins; J Beresford
Journal:  Postgrad Med J       Date:  1980-03       Impact factor: 2.401
  2 in total
  5 in total

1.  The refractory ulcer.

Authors:  D W Piper
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

2.  Cimetidine and ulcers.

Authors:  M P Lance
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

3.  Prognosis of chronic duodenal ulcer: a prospective study of the effects of demographic and environmental factors and ulcer healing.

Authors:  R W Nasiry; J H McIntosh; K Byth; D W Piper
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

4.  Symptomatic cimetidine treatment of duodenal and prepyloric ulcers.

Authors:  S Gustavsson; H O Adami; L Lööf; A Nyberg; O Nyrén
Journal:  Dig Dis Sci       Date:  1986-01       Impact factor: 3.199

Review 5.  The H2-receptor antagonist era in duodenal ulcer disease.

Authors:  I N Marks
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.